Clinical Trials in San Francisco

Showing 5701-5720 of 9,883 trials

Flortaucipir PET Imaging in Subjects With FTD

NCT03040713

This study is designed to assess the usefulness of flortaucipir in Positron Emission Tomography (PET) imaging for subjects diagnosed with Frontotemporal Dementia (FTD).

Frontotemporal Dementia

Avid Radiopharmaceuticals16 participantsStarted Apr 2017

La Jolla, California, United States • San Francisco, California, United States • Dallas, Texas, United States

COMPLETEDPhase 4< 1 mile

EVOLVE Short DAPT Study

NCT02605447

The EVOLVE Short DAPT Study is a prospective, multicenter, single-arm study designed to assess the safety of 3-month DAPT in subjects at high risk for bleeding undergoing PCI with a SYNERGY Stent System.

Coronary Artery Disease

Boston Scientific Corporation2,009 participantsStarted Feb 2016

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +107 more locations

Flortaucipir PET Imaging in Subjects With FTD

EVOLVE Short DAPT Study

Find Trials by Condition in San Francisco

A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene

Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma

Integrative Exercise for Post-Deployment Stress

Establishing Clinical Utility of a New Diagnostic Test in Patients Undergoing Cardiac Catheterization

Multi-Center Study of Iron Overload: Survey Study (MCSIO)

A Contralateral Dispensing Clinical Trial of Study Test Sapphire Lens Against Enfilcon A Silicone Hydrogel Lens

Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study

A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).

Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease

A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001

Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery

PROMINENT-Eye Ancillary Study (Protocol AD)

Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting

A Study of Filanesib (ARRY-520) and Carfilzomib in Patients With Advanced Multiple Myeloma

A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530

Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis

Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib

A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer